Symetria doctors follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and their own expertise with decades in the field.
American Society of Addiction Medicine (ASAM). (2020). National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. https://www.asam.org/docs/default-source/quality-science/npg-jam-supplement.pdf?sfvrsn=a00a52c2_2
Axelrod, S. R. (2019). Dialectical behaviour therapy for substance use disorders. In M. A. Swales (Ed.), The Oxford handbook of dialectical behaviour therapy (p. 595–614). Oxford University Press
Behar, E., Bagnulo, R., Knight, K., Santos, G., Coffin, P. O. (2020). “Chasing the pain relief, not the high”: Experiences managing pain after opioid reductions among patients with HIV and a history of substance use. PLoS One, 15(3), 1-16. https://doi.org/10.1371/journal.pone.0230408
Bruneau, J., Ahamad, K., Goyer, M. E., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018). Management of opioid use disorders: a national clinical practice guideline. CMAJ, 190(9), 247-257. https://doi.org/10.1503/cmaj.170958
Carson, L. (2019). Stigma associated with opioid use disorders in adolescents limits naloxone prescribing. Journal of Pediatric Nursing, 49, 92-96. https://doi.org/10.1016/j.pedn.2019.10.005
Cicero, T. J., Ellis, M. S., & Kasper, Z. A. (2020). Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis. American Journal of Public Health, 110(2), 244–250. https://doi.org/10.2105/AJPH.2019.305412
Dorsey, K. (2020). Supervised injection facilities and harm prevention in recreational drug users. Physician’s Assistant Program Capstones, 54. https://scholarlycommons.pacific.edu/pa-capstones/54
Eggleston, W., Calleo, V., & Kim, M. (2020). Naloxone administration by untrained community members. Pharmacotherapy, 40(1), 84-88. https://doi.org/10.1002/phar.2352
Evans, T. I., Hadland, S. E., Clark, M. A., Green, T. C., & Marshall, B. D. (2016). Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically. Harm reduction journal, 13(1), 24. https://doi.org/10.1186/s12954-016-0113-2
Faghir-Gangi, M., Rastad, H., Nejat, S., Rahimi-Movaghar, A., Yazdani, K., & Mirzazadeh, A. (2020). Understanding the reasons for sharing syringes or needles to inject drugs: conventional content analysis. Addiction & Health, 12(2), 98-108. https://doi.org/10.22122/ahj.v12i2.255
Garland, E. L., Baker, A. K., Riquino, M. R., Priddy, S. E. (2020). Mindfulness-oriented recovery enhancement. In I. Ivtzan (Ed.), Handbook of Mindfulness-Based Programmes: Mindfulness Interventions from Education to Health and Therapy. (n.p.). Routledge.
Goodyear, T., Mniszak, C., Jenkins, E., Fast, D., & Knight, R. (2020). “Am I gonna get in trouble for acknowledging my will to be safe?”: Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis. Harm Reduction Journal, 17(1), 1–14. https://doi.org/10.1186/s12954-020-00365-4
Hanson, B. L., Porter, R. R., Zold, A. L., & Terhorst-Miller, H. (2020). Preventing opioid overdose with peer-administered naloxone: findings from a rural state. Harm Reduction Journal, 17, Artile 4. https://doi.org/10.1186/s12954-019-0352-0
Harm Reduction Coalition. (2018). The Principles of Harm Reduction. http://harmreduction.org/about-us/principles-of-harm-reduction/
Harm Reduction International. (2021). What is harm reduction? https://www.hri.global/what-is-harm-reduction
Hawk, M., Coulter, R. W. S., Egan, J. E., Fisk, S. Friedman, M. R., Tula, M. & Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14, Article 70. https://doi.org/10.1186/s12954-017-0196-4
Kerr, J., Atlas, M., Crabtree, W., Chen, Y.-T., & Moyer, S. (2019). Examining Social-Ecological Factors in Developing the Louisville Metro Department of Public Health and Wellness Syringe Exchange Program. American Journal of Public Health, 109(3), 454–457. https://doi.org/10.2105/AJPH.2018.304897
Liu, T., Shi, J., Epstein, D. H., Bao, Y-P., & Lu, Lin. (2009). A meta-analysis of acupuncture combined with opioid receptor agonists for treatment of opiate-withdrawal symptoms. Cellular and Molecular Neurobiology, 29: 449-454.
Office of the Surgeon General. (2018). U.S. Surgeon General’s advisory on naloxone and opioid overdose. U.S. Department of Health & Human Services. https://www.hhs.gov/surgeongeneral/priorities/opioids-and-addiction/naloxone-advisory/index.html
Raihan, N. & Cogburn, M. (2020). Stage of Change Theory. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK556005/
Spas, J. J., Buscemi, J., Prasad, R., Janke, E. A., & Nigg, C. R. (2020). The Society of Behavioral Medicine supports an increase in funding for Medication-Assisted-Treatment (MAT) to address the opioid crisis. Translational Behavioral Medicine, 10(2), 486–488. https://doi.org/10.1093/tbm/ibz004
Spaulding, S. D. & Canady, B. E. (2020). Barriers to needle return in harm reduction programs. Professional Psychology: Research and Practice, 51(1), 10-15. http://dx.doi.org/10.1037/pro0000263
Strayer, R.J., Hawk, K., Hayes, B.D., Herring, A.A., Ketcham, E., LaPietra, A.M., Lynch, J.J., Motov, S., Repanshek, Z., Weiner, S.G., & Nelson, L.S. (2019). Management of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine. American Academy of Emergency Medicine. https://www.aaem.org/UserFiles/file/AAEMOUDWhitePaperManuscript.pdf
Stopka, T. J., Donahue, A., Hutchenson, M., Green, T. C. (2017). Nonprescription Naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts. Journal of the American Pharmacists Association, 57, S34-S44.
Strike, C., & Miskovic, M. (2018). Scoping out the literature on mobile needle and syringe programs – Review of service delivery and client characteristics operation, utilization, referrals, and impact. Harm Reduction Journal, 15, 6.
Strike, C., & Watson, T. M. (2017). Relationships between needle and syringe programs and police: An exploratory analysis of the potential role of in-service training. Drug and Alcohol Dependence, 175, 51-54.
Substance Abuse and Mental Health Services Administration (SAMHSA). (2018). Treatment Improvement Protocol (TIP) Series, no. 63. Chapter 3A: Overview of Pharmacotherapy for Opioid Use Disorder. https://www.ncbi.nlm.nih.gov/books/NBK535278/
Substance Abuse and Mental Health Services Administration. (2019). Treatment Improvement Protocol 35: Enhancing Motivation for change in substance use disorder treatment. https://store.samhsa.gov/sites/default/files/d7/priv/tip35_final_508_compliant_-_02252020_0.pdf
Taylor, E., Timko, C., Harris, A.H.S., Yu, M., & Finlay, A.K. (2019). Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration. Addiction Science & Clinical Practice, 14(1). 1. https://doi.org/10.1186/s13722-018-0129-x
Vakharia, S. P. & Little, J. (2017). Starting where the client is: Harm reduction guidelines for clinical social work practice. Clinical Social Work Journal, 45, 65-76. https://doi.org/10.1007/s10615-016-0584-3
All content is for informational purposes only. No material on this site, whether from our doctors or the community, is a substitute for seeking personalized professional medical advice, diagnosis or treatment. Never disregard advice from a qualified healthcare professional or delay seeking advice because of something you read on this website.